跳至主要内容
临床试验/NCT01051947
NCT01051947撤回不适用

Impact of Nebivolol on Central Aortic Pressure

Creighton University1 个研究点 分布在 1 个国家开始时间: 2009年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Stable blood pressure

研究概览

简要总结

A randomized, cross-over, single-blind study to compare the effects of nebivolol and metoprolol on central aortic pressure and peripheral brachial pressure in patients with stable cardiovascular disease.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
45 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects with history of hypertension
  • Subjects who have received metoprolol for a minimum of 3 months

排除标准

  • Patients who have had an acute myocardial infarction, coronary revascularization or who have been hospitalized for heart failure or cardiac arrhythmia in the past 6 months

研究组 & 干预措施

Metoprolol

Experimental

Metoprolol therapy for 2-6 weeks depending on blood pressure readings

干预措施: Metoprolol (Drug)

Nebivolol

Experimental

Nebivolol therapy for 2-6 weeks depending on blood pressure readings

干预措施: Nebivolol (Drug)

结局指标

主要结局

Stable blood pressure

时间窗: 6 months

Subjects will be randomized to nebivolol or metoprolol. Their medication will be titrated so that their blood pressure is within 10% of their initial reading.

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验